Form 4: LifeStance Health Group CEO Kenneth Burdick Reports Acquisition of Common Stock and Vesting of Restricted Stock Units

LifeStance Health Group's CEO, Kenneth Burdick, reports acquiring common stock and vesting of restricted stock units, increasing his beneficial ownership.

Summary

• On March 8, 2024, Kenneth A. Burdick, CEO of LifeStance Health Group, acquired 364,077 restricted stock units (RSUs), each representing a contingent right to receive one share of the company's common stock.
• Additionally, Mr. Burdick acquired 423,790 performance-based restricted stock units that vested on the same date.
• These transactions increased Mr. Burdick's direct ownership to 2,725,187 shares due to the RSUs and 3,148,977 shares due to the performance based restricted stock units.
• The transactions were reported on a Form 4 filing with the SEC on March 12, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports transactions related to executive compensation. The vesting of performance based RSUs is a slightly positive sign.

Positives

• The vesting of performance-based restricted stock units suggests that performance targets were met, which could be viewed positively.

Industry Context

Form 4 filings are routine disclosures required by the SEC when insiders, such as officers and directors, trade in their company's stock. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

• The increased ownership by the CEO could signal confidence in the company's future performance to shareholders.

Key Dates